30 Participants Needed

Group Therapy for Psychosocial Issues

(Group PM+ Trial)

DR
ME
Overseen ByMaureen E Lyon, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Children's National Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 7 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

Participants are being asked to be in the study if they are the parent or legal guardian of a child (\>1 year or \<18 years old) with a rare condition. The group based psychoeducational intervention is called Rare Group Problem Management Plus. Rare Group PM Plus may help adults with practical and emotional problems. It is a group program (there will be other men or women with similar problems) It happens once a week for 5 weeks (each session lasts 90 minutes) Participants will complete assessments before they start Rare Group PM+. Participants will also complete the same assessments within a few weeks of completing Rare Group PM+. Assessments should only take one hour. Study visits are by Telemedicine. Participants will need a smart phone or tablet. If they do not have a smart phone or tablet, the study team will help with this. Participants will not receive any materials or money or medication.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on group therapy and does not involve medication changes.

What data supports the effectiveness of the treatment Group Therapy for Psychosocial Issues?

Research shows that problem-solving therapy, when combined with other management strategies, can improve outcomes for people with depression and disability. Additionally, patient-managed problem-solving groups have been effective in increasing responsible behavior in patients with chronic mental illness.12345

Is Group Problem Management Plus (PM+) safe for humans?

Group Problem Management Plus (PM+) has been used safely in various settings, including for people affected by adversity in low- and middle-income countries. It is a brief intervention delivered by non-specialists and has been evaluated for its feasibility and acceptability, indicating it is generally safe for human use.678910

What makes Group Problem Management Plus (PM+) unique compared to other treatments for psychosocial issues?

Group Problem Management Plus (PM+) is unique because it combines problem-solving strategies with group therapy, allowing participants to support each other while learning practical skills to manage their issues. This approach is cost-effective and can be particularly beneficial for those who need extended support, as it leverages the social dynamics of group settings to enhance learning and motivation.1112131415

Research Team

ML

Maureen Lyon, PhD

Principal Investigator

Children's National Research Institute

Eligibility Criteria

This trial is for parents or guardians of children aged 1 to 17 with a rare condition. They should be able to attend weekly group sessions via telemedicine using a smartphone or tablet, which the study team can assist in providing if necessary.

Inclusion Criteria

Understands and speaks English or Spanish. Reading or health literacy is not required
Signed consent
Signed waiver of assent for child
See 1 more

Exclusion Criteria

My family caregiver is younger than 18.
My child with a rare disease is older than 21.
Family caregiver is actively suicidal, homicidal, or psychotic
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Assessment

Participants complete assessments before starting the Rare Group PM+ intervention

1 week
1 visit (telemedicine)

Treatment

Participants undergo the Rare Group PM+ intervention, consisting of 5 weekly sessions

5 weeks
5 visits (telemedicine)

Follow-up

Participants complete assessments within 2 weeks after completing the Rare Group PM+ intervention

2 weeks
1 visit (telemedicine)

Treatment Details

Interventions

  • Rare Group Problem Management Plus
Trial Overview The intervention being tested is called Rare Group Problem Management Plus, a psychoeducational program aimed at helping adults manage practical and emotional challenges through weekly group sessions over five weeks.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Rare Group PM PlusExperimental Treatment1 Intervention
Rare Group PM Plus consists of 5 weekly sessions. Each session lasts 90 minutes. Session 1: Managing Stress Session 2: Managing Problems Session 3: Get Going, Keep Doing Session 4: Strengthening Social Support Session 5: Staying Well and Looking Forward

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's National Research Institute

Lead Sponsor

Trials
227
Recruited
258,000+

Travere Therapeutics, Inc.

Industry Sponsor

Trials
23
Recruited
103,000+

Findings from Research

The use of patient-managed problem-solving groups in inpatient settings effectively increased responsible behaviors among patients with chronic mental illness, as shown by a repeated measures design.
This intervention led to a higher frequency of targeted behaviors compared to baseline periods, suggesting its potential applicability for various behaviors in different treatment environments.
Using written communication with patient groups to promote behavioral change in chronic mentally ill patients.Elder, AD., Zultowsky, D.[2019]
In a study involving 171 depressed, disabled, low-income patients aged 60 and older, both clinical case management (CM) and integrated problem-solving therapy (CM-PST) showed similar effectiveness in reducing depressive symptoms over 12 weeks, indicating that CM alone is sufficient for this population.
The development of problem-solving skills did not mediate the improvement in depression, suggesting that the benefits of CM do not rely on this specific therapeutic approach.
Clinical Case Management versus Case Management with Problem-Solving Therapy in Low-Income, Disabled Elders with Major Depression: A Randomized Clinical Trial.Alexopoulos, GS., Raue, PJ., McCulloch, C., et al.[2022]
A randomized controlled trial involving 171 low-income individuals aged 60 and older with major depression showed that both clinical case management (CM) and integrated problem-solving therapy (CM-PST) significantly improved functional outcomes over 12 weeks, with benefits lasting up to 24 weeks.
Interestingly, CM was found to be just as effective as CM-PST, indicating that the additional problem-solving therapy may not be necessary for improving function in this population, while improvements in self-efficacy, problem-solving skills, and depression symptoms were key predictors of functional improvement.
Effects of Problem-Solving Therapy and Clinical Case Management on Disability in Low-Income Older Adults.Areรกn, PA., Raue, PJ., McCulloch, C., et al.[2018]

References

Using written communication with patient groups to promote behavioral change in chronic mentally ill patients. [2019]
Clinical Case Management versus Case Management with Problem-Solving Therapy in Low-Income, Disabled Elders with Major Depression: A Randomized Clinical Trial. [2022]
Effects of Problem-Solving Therapy and Clinical Case Management on Disability in Low-Income Older Adults. [2018]
Matching clients to group therapies based on psychological readiness. [2013]
[Primary psychosomatic management in general practice. Results of a German nationwide demonstration project of quality assurance]. [2008]
Feasibility of Group Problem Management Plus (PM+) to improve mental health and functioning of adults in earthquake-affected communities in Nepal. [2020]
Residual posttraumatic stress disorder symptoms after provision of brief behavioral intervention in low- and middle-income countries: An individual-patient data meta-analysis. [2022]
Lay-therapist-delivered, low-intensity, psychosocial intervention for refugees and asylum seekers (PROSPER): protocol for a pilot randomised controlled trial. [2021]
Effectiveness of Group Problem Management Plus (Group-PM+) for adults affected by humanitarian crises in Nepal: study protocol for a cluster randomized controlled trial. [2021]
A qualitative evaluation of a brief multicomponent intervention provided by lay health workers for women affected by adversity in urban Kenya. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Group psychotherapy in an HMO. [2016]
[Group psychotherapy in psychiatry]. [2006]
13.United Statespubmed.ncbi.nlm.nih.gov
A psychotherapeutic group for men. [2019]
14.United Statespubmed.ncbi.nlm.nih.gov
A group psychotherapy model for acute treatment settings. [2015]
Group Psychotherapy in Norway. [2016]